The Giant Virus in the Room: Corporate Vaccine Makers Need More Pandemics, to Grow

As drug makers prepare to make a killing on supposed vaccines against COVID-19, it is important, particularly for those who consider vaccines to be a wise investment today, or those whose retirement savings might get invested in such vaccines without … Continue reading →

COVID-19: Diagnostics, Treatments, and Long-Term Solutions

The first infection by the agent of COVID-19, variously called 2019-nCoV or SARS-CoV-2, probably happened around December 12, 2019, based on the interviews in late December with a group of new pneumonia patients in Wuhan, China. Most of the pneumonia … Continue reading →

COVID-19: Background Science to Understand the Pandemic

Pathogenic RNA viruses began to prey in earnest on humans around the time of our industrial revolution. As the human population exploded and then increased its density by a massive effort of urbanization, it also changed land use to encroach … Continue reading →